Magnesium sulfate (Epsom salt)
Also called Epsom salt, Epsom salts, magnesium sulphate, MgSO4, magnesium sulfate heptahydrate. One of 9 forms of magnesium compared on this page.
Grade B for sulfate itself: functional constipation in women (mineral water) Mineral Last checked
The short answer
From 25 sourcesMagnesium sulfate is Epsom salt: about 10% magnesium by weight and an over-the-counter saline laxative. Mineral waters rich in magnesium sulfate eased functional constipation in several trials (grade B). No controlled study shows that Epsom baths raise body magnesium. Swallowed in large amounts it can cause dangerous magnesium levels.
Every graded outcome on this page
7 rows · line = participants- BGrade BFunctional constipation in women (mineral water)Tested sulfaten 244
- BGrade BTreatment response in functional constipation (mineral water)Tested sulfaten 226
- BGrade BBowel movements and stool consistency in functional constipationTested sulfaten 75
- CGrade CBowel movement frequency in functional constipationTested sulfaten 100
- DGrade DArterial stiffness and blood pressure (daily supplement)Tested sulfaten 164
- DGrade DGut transit speed and stool weight (oral laxative dose)Tested sulfaten 8
- ∅No effectNight-time leg cramps in older adults (magnesium in any form)Other or mixed formsn 307
- 1 more graded outcome, in the evidence chapter
Key facts
- Elemental magnesium
- About 9.9% of Epsom salt (the heptahydrate) is magnesium: a 5 g teaspoon holds 495 mg; anhydrous magnesium sulfate is about 20% magnesium123
- What the label is for
- US Epsom salt is an OTC saline laxative for occasional constipation that generally works in 30 minutes to 6 hours; many packs also list a soak for minor sprains and bruises14
- Laxative dose vs upper limit
- Adult label directions of 10 to 30 g a day give 990 to 2,970 mg of magnesium, several times the 350 mg/day upper limit for supplemental magnesium, which is why the label is for occasional, short use15
- Strongest human evidence
- Functional constipation (B): 1 L a day of a magnesium sulfate-rich mineral water helped more women than low-mineral water within 2 weeks in two French trials (244 and 226 people)67
- Baths and soaks
- A 2017 review concluded that claims for transdermal magnesium, salt baths included, are scientifically unsupported11
- As a daily supplement
- 450 mg/day of magnesium as sulfate for 24 weeks raised blood magnesium about as much as citrate or oxide but did not change arterial stiffness or blood pressure10
What it is
Magnesium sulfate is the magnesium salt sold as Epsom salt, an over-the-counter saline laxative and bath soak; also a hospital injection.
How it works
EstablishedTaken by mouth, magnesium sulfate acts as an osmotic laxative: it keeps water in the large bowel, which speeds transit and improves stool consistency; in volunteers, an oral dose accelerated small-bowel transit and raised stool weight. Magnesium that is absorbed is cleared only by the kidneys, so blood levels can climb when large amounts are swallowed or kidney function is poor. Injected magnesium blocks neuromuscular transmission and reduces acetylcholine release at the motor end-plate, the basis of its use against eclamptic seizures.1781412
Compound weight to elemental magnesium
Arithmetic, not advice50mg elemental magnesium500 mg epsom salt crystals (magnesium sulfate heptahydrate, usp) × 9.9%
Forms side by side: Epsom crystals, soaks, mineral water, capsules and injection
9 forms named in our sources, each with a page of its own. Citation numbers in a column link to the page that holds them.
Magnesium forms compared
9 forms · 9 with a page · Sulfate (Epsom salt) highlighted| 9 forms | Sulfate (Epsom salt)You are here | Glycinate (bisglycinate)Read the page | CitrateRead the page | L-threonateRead the page | MalateRead the page | TaurateRead the page | OxideRead the page | ChlorideRead the page | OrotateRead the page |
|---|---|---|---|---|---|---|---|---|---|
| Elemental shareOf compound weight | 9.9%12MgSO4·7H2O: 24.3 ÷ 246.5 = 9.9% magnesium; the label gives 495 mg magnesium per 5 g teaspoon | 14.1%10Mg(C2H4NO2)2, anhydrous MW 172.42 | 16.2%12Mg3(C6H5O7)2 (trimagnesium dicitrate), anhydrous MW 451.12 | 8.3%5Mg(C4H7O5)2, anhydrous MW 294.50 | 15.5%19MgC4H4O5, anhydrous MW 156.38 | 8.9%20Mg(C2H6NO3S)2, anhydrous MW 272.6 | 60.3%6MgO, MW 40.305 | 12%213Magnesium chloride hexahydrate MgCl2·6H2O, MW 203.30 (anhydrous MgCl2, MW 95.21, is 25.5% magnesium) | 6.6%26Dihydrate C10H10MgN4O10, MW 370.51 (6.6% Mg); anhydrous C10H6MgN4O8, MW 334.48 (7.3% Mg); Mg 24.305 g/mol |
| Form-specific evidenceOutcomes tested on this form | BGrade BFunctional constipation in women (mineral water)Tested this formRCT, n 244, 2014 BGrade BTreatment response in functional constipation (mineral water)Tested this formRCT, n 226, 2019 +4 more on its page | CGrade CInflammation markers and lung function in asthma and COPDTested this formRCT, n 224, 2026 CGrade CInsomnia severityTested this formRCT, n 155, 2025 +1 more on its page | CGrade CArterial stiffness and blood pressureTested this formRCT, n 164, 2022 CGrade CMigraine attack frequencyTested this formRCT, n 81, 1996 +4 more on its page | CGrade COverall cognitive performanceTested this formRCT, n 100, 2025 CGrade COpioid dose needed for pain in advanced cancerTested this formRCT, n 83, 2023 +2 more on its page | No form-specific graded outcome yet | No form-specific graded outcome yet | BGrade BOverall improvement in chronic constipationTested this formRCT, n 90, 2021 BGrade BOverall improvement in chronic constipationTested this formRCT, n 34, 2019 +2 more on its page | CGrade CMetabolic syndrome and its components in adults with low magnesiumTested this formRCT, n 198, 2018 CGrade CMild-to-moderate depression and anxiety symptomsTested this formCrossover RCT, n 126, 2017 +10 more on its page | CGrade CHeart-rhythm, blood-pressure and related problemsTested this formMeta-analysis, n 1,190, 2015 CGrade CSurvival and symptoms in severe heart failureTested this formRCT, n 79, 2009 +2 more on its page |
| Studied dosesRange in its trials | No data yet | 100–250mgelemental magnesium (as glycinate/bisglycinate)342827 | 290–600mgelemental magnesium (as citrate)61522212310 | 83–165mgelemental magnesium (1–2 g/day of magnesium L-threonate compound)534192 | 250–600mgmg of elemental magnesium per day (with malic acid)361 | 121mgmg of elemental magnesium per day3 | 500–1,500mgmg of magnesium oxide (compound) per day834512 | 248–450mgElemental magnesium per day as stated in the oral trials13481415 | 1,878–6,000mgmg of magnesium orotate compound per day (not elemental magnesium)347 |
| Absorption in people | Acts mainly in the bowel as an osmotic laxative: it keeps water in the large bowel and speeds transit.178 | Similar to oxide overall in 12 ileal-resection patients (23.5% vs 22.8%); higher in the 4 poorest oxide absorbers.11 | Beat oxide on urinary and serum magnesium in short human studies.1314 | No human head-to-head data; rat data only.16 | No human comparison; highest serum AUC of five compounds in rats.22 | No human data; fast absorption and highest brain levels in rats (acetyl taurate).22 | About 4% fractional absorption in one comparison, the lowest tested.2113 | ODS: small studies find chloride, citrate, aspartate and lactate absorbed more completely than oxide or sulfate.1 | No head-to-head human absorption data in our sources.1 |
| GI tolerance | Works as a laxative within 30 minutes to 6 hours; the label warns against use with kidney disease, a magnesium-restricted diet or abdominal pain, nausea or vomiting.1 | All 12 crossover patients tolerated it better than oxide.11 | Diarrhea in 18.6% at 600 mg/day (12-week migraine trial).15 | Well tolerated at 1–2 g/day for 3–6 weeks.1718 | No form-specific human data. | No serious adverse events in one 3-month study (taurate with potassium citrate).23 | Among the forms ODS links most often to diarrhea.1 | ODS lists chloride among the forms most commonly reported to cause diarrhea at high doses.1 | Large magnesium doses from supplements commonly cause diarrhoea, nausea and abdominal cramping.1 |
| Studied for | Occasional constipation (OTC label); transit studies (D) | Insomnia severity (one RCT). | Arterial stiffness (no effect), bone turnover, migraine. | Cognition and sleep (small RCTs). | Fibromyalgia (one small trial). | Blood pressure (one uncontrolled study). | Constipation, migraine; arterial stiffness null. | Glucose, insulin resistance, blood pressure and CRP in adults with low magnesium; depression symptoms; heart rhythm in heart failure. | Heart failure, heart rhythm and blood pressure (Russian trials) |
- Magnesium sulfate (Epsom salt)You are here
- Elemental share
- 9.9%12MgSO4·7H2O: 24.3 ÷ 246.5 = 9.9% magnesium; the label gives 495 mg magnesium per 5 g teaspoon
- Form-specific evidence
- BGrade BFunctional constipation in women (mineral water)Tested this formRCT, n 244, 2014BGrade BTreatment response in functional constipation (mineral water)Tested this formRCT, n 226, 2019+4 more on its page
- Studied doses
- No data yet
- Absorption in people
- Acts mainly in the bowel as an osmotic laxative: it keeps water in the large bowel and speeds transit.178
- GI tolerance
- Works as a laxative within 30 minutes to 6 hours; the label warns against use with kidney disease, a magnesium-restricted diet or abdominal pain, nausea or vomiting.1
- Studied for
- Occasional constipation (OTC label); transit studies (D)
- Magnesium glycinate (bisglycinate)Read the page
- Elemental share
- 14.1%10Mg(C2H4NO2)2, anhydrous MW 172.42
- Form-specific evidence
- CGrade CInflammation markers and lung function in asthma and COPDTested this formRCT, n 224, 2026CGrade CInsomnia severityTested this formRCT, n 155, 2025+1 more on its page
- Absorption in people
- Similar to oxide overall in 12 ileal-resection patients (23.5% vs 22.8%); higher in the 4 poorest oxide absorbers.11
- GI tolerance
- All 12 crossover patients tolerated it better than oxide.11
- Studied for
- Insomnia severity (one RCT).
- Magnesium citrateRead the page
- Elemental share
- 16.2%12Mg3(C6H5O7)2 (trimagnesium dicitrate), anhydrous MW 451.12
- Form-specific evidence
- CGrade CArterial stiffness and blood pressureTested this formRCT, n 164, 2022CGrade CMigraine attack frequencyTested this formRCT, n 81, 1996+4 more on its page
- GI tolerance
- Diarrhea in 18.6% at 600 mg/day (12-week migraine trial).15
- Studied for
- Arterial stiffness (no effect), bone turnover, migraine.
- Magnesium L-threonateRead the page
- Elemental share
- 8.3%5Mg(C4H7O5)2, anhydrous MW 294.50
- Form-specific evidence
- CGrade COverall cognitive performanceTested this formRCT, n 100, 2025CGrade COpioid dose needed for pain in advanced cancerTested this formRCT, n 83, 2023+2 more on its page
- Absorption in people
- No human head-to-head data; rat data only.16
- Studied for
- Cognition and sleep (small RCTs).
- Magnesium malateRead the page
- Magnesium taurateRead the page
- Elemental share
- 8.9%20Mg(C2H6NO3S)2, anhydrous MW 272.6
- Form-specific evidence
- No form-specific graded outcome yet
- Studied doses
- 121mgmg of elemental magnesium per day3
- Absorption in people
- No human data; fast absorption and highest brain levels in rats (acetyl taurate).22
- GI tolerance
- No serious adverse events in one 3-month study (taurate with potassium citrate).23
- Studied for
- Blood pressure (one uncontrolled study).
- Magnesium oxideRead the page
- Elemental share
- 60.3%6MgO, MW 40.305
- Form-specific evidence
- BGrade BOverall improvement in chronic constipationTested this formRCT, n 90, 2021BGrade BOverall improvement in chronic constipationTested this formRCT, n 34, 2019+2 more on its page
- GI tolerance
- Among the forms ODS links most often to diarrhea.1
- Studied for
- Constipation, migraine; arterial stiffness null.
- Magnesium chlorideRead the page
- Elemental share
- 12%213Magnesium chloride hexahydrate MgCl2·6H2O, MW 203.30 (anhydrous MgCl2, MW 95.21, is 25.5% magnesium)
- Form-specific evidence
- CGrade CMetabolic syndrome and its components in adults with low magnesiumTested this formRCT, n 198, 2018CGrade CMild-to-moderate depression and anxiety symptomsTested this formCrossover RCT, n 126, 2017+10 more on its page
- Absorption in people
- ODS: small studies find chloride, citrate, aspartate and lactate absorbed more completely than oxide or sulfate.1
- GI tolerance
- ODS lists chloride among the forms most commonly reported to cause diarrhea at high doses.1
- Studied for
- Glucose, insulin resistance, blood pressure and CRP in adults with low magnesium; depression symptoms; heart rhythm in heart failure.
- Magnesium orotateRead the page
- Elemental share
- 6.6%26Dihydrate C10H10MgN4O10, MW 370.51 (6.6% Mg); anhydrous C10H6MgN4O8, MW 334.48 (7.3% Mg); Mg 24.305 g/mol
- Form-specific evidence
- CGrade CHeart-rhythm, blood-pressure and related problemsTested this formMeta-analysis, n 1,190, 2015CGrade CSurvival and symptoms in severe heart failureTested this formRCT, n 79, 2009+2 more on its page
- Absorption in people
- No head-to-head human absorption data in our sources.1
- GI tolerance
- Large magnesium doses from supplements commonly cause diarrhoea, nausea and abdominal cramping.1
- Studied for
- Heart failure, heart rhythm and blood pressure (Russian trials)
Elemental magnesium in 1,000 mg of each form
mg per 1,000 mg of compoundWhat the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Grade B for sulfate itself. 6 outcomes on this page were tested with sulfate: functional constipation in women (mineral water); treatment response in functional constipation (mineral water); bowel movements and stool consistency in functional constipation; bowel movement frequency in functional constipation; arterial stiffness and blood pressure (daily supplement); gut transit speed and stool weight (oral laxative dose) (RCT, n 244, 2014). Rows that tested other or mixed forms describe magnesium in general, not sulfate. For the overall evidence, see the Magnesium page.
Trial map
7 graded outcomes, largest study first7 graded outcomes: 4 improved, 1 mixed, 2 no effect. The largest, a 2020 meta-analysis of 307 people on Night-time leg cramps in older adults (magnesium in any form), found no effect.
1Night-time leg cramps in older adults (magnesium in any form)
No effect · No-effect grade · Meta-analysis, 307 people, 2020
Mostly older adults with idiopathic cramps, presumed nocturnal leg cramps, in 5 trials
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Night-time leg cramps in older adults (magnesium in any form) | No effect | 307 | No-effect grade · Meta-analysis, 2020 | Mostly older adults with idiopathic cramps, presumed nocturnal leg cramps, in 5 trials |
| Functional constipation in women (mineral water) | Improved | 244 | Grade B · RCT, 2014 | Women aged 18 to 60 with functional constipation (Rome III), recruited by 62 French general practitioners |
| Treatment response in functional constipation (mineral water) | Improved | 226 | Grade B · RCT, 2019 | Outpatients with functional constipation in a multicentre trial |
| Arterial stiffness and blood pressure (daily supplement) | No effect | 164 | Grade D · RCT, 2022 | Overweight or slightly obese adults, mean age 63.2, 63.4% women; four arms (citrate, oxide, sulfate, placebo) |
| Bowel movement frequency in functional constipation | Mixed | 100 | Grade C · RCT, 2016 | Adults with functional constipation (Rome III) |
| Bowel movements and stool consistency in functional constipation | Improved | 75 | Grade B · RCT, 2017 | Otherwise healthy adults with functional constipation (106 randomized; 75 in the 500 mL arms) |
| Gut transit speed and stool weight (oral laxative dose) | Improved | 8 | Grade D · Crossover RCT, 2000 | Healthy volunteers (four women, four men), aged about 21 |
Every graded row
7 rowsShowing 7 of 7 outcomes. Human trials only.
BGrade BFunctional constipation in women (mineral water)Constipation · tested sulfate37.5% vs 21.1% improvedRCT
n 244 · 2014
Improved At week 2, constipation was reduced in 37.5% with 1 L/day of Hépar vs 21.1% with low-mineral water (P = 0.013); 0.5 L/day gave 30.9% (P = 0.099). The 1 L group also had fewer hard stools and used less rescue medication. No serious adverse events.
- Design
- RCT, n = 244, 2014
- Population
- Women aged 18 to 60 with functional constipation (Rome III), recruited by 62 French general practitioners
- Form
- Magnesium sulfate-rich natural mineral water (Hépar) vs low-mineral water
- Dose
- 0.5 L or 1 L/day of Hépar within 1.5 L/day of water
- Duration
- 4 weeks
- Source
- Reference 6 · PubMed 24342746 (opens PubMed)
BGrade BTreatment response in functional constipation (mineral water)Constipation · tested sulfate50% vs 29% respondersRCT
n 226 · 2019
Improved More people responded with Hépar than with low-mineral water at day 14 (50% vs 29%, P = 0.001), and mean time to response was shorter (6.4 vs 7.3 days). Safety results were good.
- Design
- RCT, n = 226, 2019
- Population
- Outpatients with functional constipation in a multicentre trial
- Form
- Magnesium sulfate-rich natural mineral water (Hépar) vs low-mineral water
- Dose
- 1 L/day within 1.5 L/day of water
- Duration
- 14 days
- Source
- Reference 7 · PubMed 31170680 (opens PubMed)
BGrade BBowel movements and stool consistency in functional constipationConstipation · tested sulfateBetter stool consistency and frequencyRCT
n 75 · 2017
Improved Complete spontaneous bowel movements per week tended to rise more with the mineral water (one-sided p = 0.036); spontaneous bowel movements, stool consistency and constipation symptoms improved significantly versus placebo.
- Design
- RCT, n = 75, 2017
- Population
- Otherwise healthy adults with functional constipation (106 randomized; 75 in the 500 mL arms)
- Form
- Natural mineral water rich in magnesium sulfate and sodium sulfate (Donat Mg) vs placebo water
- Dose
- 500 mL/day (300 mL arms stopped at interim analysis)
- Duration
- 6 weeks
- Source
- Reference 15 · PubMed 26582579 (opens PubMed)
CGrade CBowel movement frequency in functional constipationConstipation · tested sulfate+2.02 vs +0.88 a week at 3 weeksRCT
n 100 · 2016
Mixed At the primary 6-week endpoint there was no significant difference (p = 0.163). At 3 weeks, bowel movements rose by 2.02 a week with the mineral water vs 0.88 with tap water (p = 0.005).
- Design
- RCT, n = 100, 2016
- Population
- Adults with functional constipation (Rome III)
- Form
- Carbonated calcium and magnesium sulfate-rich mineral water vs carbonated tap water
- Dose
- 1 L/day (4 × 250 mL)
- Duration
- 6 weeks
- Source
- Reference 17 · PubMed 27924798 (opens PubMed)
DGrade DArterial stiffness and blood pressure (daily supplement)Heart · tested sulfateNo change vs placeboRCT
n 164 · 2022
No effect Magnesium sulfate, like oxide, had no significant effect on carotid-femoral pulse wave velocity or blood pressure. Plasma magnesium rose similarly with all three forms; urinary magnesium rose more with citrate than with oxide or sulfate.
- Design
- RCT, n = 164, 2022
- Population
- Overweight or slightly obese adults, mean age 63.2, 63.4% women; four arms (citrate, oxide, sulfate, placebo)
- Form
- Magnesium sulfate (one of three forms) vs placebo
- Dose
- 450 mg/day magnesium
- Duration
- 24 weeks
- Source
- Reference 10 · PubMed 35253448 (opens PubMed)
DGrade DGut transit speed and stool weight (oral laxative dose)Constipation · tested sulfateFaster transit in all 8Crossover RCT
n 8 · 2000
Improved Magnesium sulfate accelerated duodenum-to-caecum transit and increased faecal weight and fat in every subject; with a meal it also raised peptide YY and inhibited gallbladder emptying.
- Design
- Crossover RCT, n = 8, 2000
- Population
- Healthy volunteers (four women, four men), aged about 21
- Form
- Oral magnesium sulfate vs placebo, fasting and with a meal
- Dose
- One laxative dose per experiment
- Duration
- Four experiments
- Source
- Reference 8 · PubMed 10792122 (opens PubMed)
∅No effectNight-time leg cramps in older adults (magnesium in any form)Muscle cramps · other or mixed forms−0.18 cramps/week (n.s.)Meta-analysis · 5 studies
n 307 · 2020
No effect Cramps per week did not differ from placebo at 4 weeks (−0.18 cramps/week, 95% CI −0.84 to 0.49; moderate certainty), nor did the share of people with a 25% or better reduction. Evidence in pregnancy-associated cramps was conflicting and at high risk of bias.
- Design
- Meta-analysis, 5 studies, n = 307, 2020
- Population
- Mostly older adults with idiopathic cramps, presumed nocturnal leg cramps, in 5 trials
- Form
- Oral magnesium supplements (forms varied); one trial used intravenous infusions
- Dose
- As given in each trial
- Duration
- 4 weeks for the main outcomes
- Source
- Reference 18 · PubMed 32956536 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
One teaspoon is more than the supplement upper limit
Why grams of Epsom salt and grams of magnesium differ tenfold
The mineral-water effect in plain numbers
In the 244-woman trial, 16 more women in every 100 improved by week 2 with 1 L a day of the magnesium sulfate-rich water than with low-mineral water.6
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Doses studied in human trials ranged from 0.3 to 1 L a day of magnesium sulfate-rich mineral water for 2 to 6 weeks to 450 mg a day of elemental magnesium as magnesium sulfate for 24 weeks; a transit study used single laxative doses. The Epsom salt label's adult laxative directions are 10 to 30 g a day (990 to 2,970 mg of magnesium) for occasional use. These are research amounts and label directions, not advice.6715171081
When trials measured an effect
3 outcomes| Outcome | Measured at | Basis |
|---|---|---|
| Bowel movement (laxative dose) | Generally within 30 minutes to 6 hours | OTC Drug Facts label1 |
| Functional constipation (mineral water) | From about week 2; mean time to response 6.4 days | Two French randomized trials67 |
| Blood magnesium (daily supplement) | Measured at 24 weeks | Four-arm randomized trial10 |
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Magnesium sulfate meets
5 cited rowsMedicines 5
Supplements and foods 0
No supplement rows in our sources.
- Drug label or FDA notice
Choose a medicine or supplement above to read its cited rows here.
Also cited:
Cardiac glycosides
Drug labelDrug label or FDA notice
Cardiac glycosides, for example digoxin: The injection label advises extreme caution in patients on digitalis, because heart block can occur if calcium is needed to treat magnesium toxicity.
Source 14, Fresenius Kabi USA via DailyMed (NLM) (2026)
Neuromuscular blocking agents (general anaesthesia)
Drug labelDrug label or FDA notice
Neuromuscular blocking agents (general anaesthesia), for example Muscle relaxants used in surgery: The injection label reports excessive neuromuscular block when parenteral magnesium sulfate is given with a neuromuscular blocking agent.
Source 14, Fresenius Kabi USA via DailyMed (NLM) (2026)
Oral bisphosphonates
Drug labelDrug label or FDA notice
Oral bisphosphonates, for example alendronate: The alendronate label says antacids and oral medicines containing multivalent cations such as magnesium interfere with its absorption.
Source 21, DailyMed (NLM) (2026)
Other medicines taken by mouth
Drug labelDrug label or FDA notice
Other medicines taken by mouth, for example Any prescription or OTC medicine: The Epsom salt laxative label says to ask a doctor or pharmacist before use with any other drug and to separate it from other drugs by 2 or more hours, because laxatives may affect how other drugs work.
Source 1, Vi-Jon, LLC via DailyMed (NLM) (2026)
Tetracycline and quinolone antibiotics
Drug labelDrug label or FDA notice
Tetracycline and quinolone antibiotics, for example doxycycline, ciprofloxacin: Their labels say magnesium-containing products impair absorption; ciprofloxacin should be given at least 2 hours before or 6 hours after magnesium antacids.
Source 19, DailyMed (NLM) (2026); Source 20, DailyMed (NLM) (2026)
Interactions
5 agents| Agent | What the source says | Evidence |
|---|---|---|
| Medicines5 | ||
| Other medicines taken by mouthe.g. Any prescription or OTC medicine | The Epsom salt laxative label says to ask a doctor or pharmacist before use with any other drug and to separate it from other drugs by 2 or more hours, because laxatives may affect how other drugs work.1 | Drug label |
| Tetracycline and quinolone antibioticse.g. doxycycline, ciprofloxacin | Their labels say magnesium-containing products impair absorption; ciprofloxacin should be given at least 2 hours before or 6 hours after magnesium antacids.1920 | Drug label |
| Oral bisphosphonatese.g. alendronate | The alendronate label says antacids and oral medicines containing multivalent cations such as magnesium interfere with its absorption.21 | Drug label |
| Neuromuscular blocking agents (general anaesthesia)e.g. Muscle relaxants used in surgery | The injection label reports excessive neuromuscular block when parenteral magnesium sulfate is given with a neuromuscular blocking agent.14 | Drug label |
| Cardiac glycosidese.g. digoxin | The injection label advises extreme caution in patients on digitalis, because heart block can occur if calcium is needed to treat magnesium toxicity.14 | Drug label |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Magnesium sulfate and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Magnesium sulfate.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
6 groups- Kidney disease
- The Epsom salt label says to ask a doctor first if you have kidney disease or are on a magnesium-restricted diet; magnesium is cleared only by the kidneys.114
- Abdominal pain, nausea or vomiting
- The label says to ask a doctor before use with these symptoms, after a change in bowel habits lasting 2 weeks, or after using a laxative for more than a week, and to stop if there is rectal bleeding or no bowel movement.1
- Children
- Labels give lower amounts for ages 6 to 11 and say children under 6 should not use it without a doctor's advice.14
- Bowel conditions and large doses
- A 60-year-old woman with a past gastrectomy lost consciousness 30 minutes after swallowing Epsom salts before a colonoscopy, with a blood magnesium of 8.71 mmol/L, despite normal kidney function.13
- Pregnancy and breastfeeding
- Ask a health professional before using it as a laxative in pregnancy or breastfeeding (label). Prolonged hospital infusions beyond 5 to 7 days have caused low calcium and bone changes in the fetus. LactMed notes that infants absorb oral magnesium poorly, so maternal magnesium is not expected to affect a breastfed baby's blood magnesium.11425
- Diabetes and hot soaks
- Epsom soak directions say hot or warm soaks should not be used by people with diabetes except on a physician's advice.4
Too much magnesium
3 notesA laxative dose is many times the supplement upper limit. That is fine for occasional use as directed and dangerous when it is not.
- Case reports
- A 40-year-old woman with normal kidney function arrived after a cardiac arrest from an accidental Epsom salt overdose, and the case was fatal; another patient survived a blood magnesium of 8.71 mmol/L after swallowing Epsom salts before a colonoscopy.1213
- Signs
- The injection label lists flushing, sweating, low blood pressure, depressed reflexes, flaccid paralysis, low body temperature, and cardiac and breathing depression as signs of magnesium intoxication; loss of the knee-jerk reflex is an early sign.14
- What to do
- The OTC label says to get medical help or contact a Poison Control Center right away in case of overdose.1
Hospital uses (prescription)
4 notesInjected magnesium sulfate is a different product used under monitoring. These results do not apply to Epsom salt.
- Pre-eclampsia
- In the Magpie trial (10,141 women in 33 countries), magnesium sulfate cut eclampsia by 58% versus placebo; a Cochrane review of six trials (11,444 women) found it more than halved eclampsia, with flushing in 24% vs 5%.1622
- Acute asthma
- A single 1.2 g or 2 g infusion reduced hospital admissions in adults whose asthma attack had not responded enough to first-line treatment (14 trials, 2,313 people); in children the evidence is limited to small trials.2324
- Fetal bone effects
- The injection label warns that continuous use beyond 5 to 7 days in pregnancy can cause low calcium and bone abnormalities in the developing baby, including fractures.14
- Breastfeeding
- NIH's LactMed says intravenous magnesium raises milk magnesium only slightly and is not expected to affect the infant's blood magnesium, though 24-hour postpartum infusions may delay the start of lactation.25
How to read the label
What to check on the Supplement Facts panel.
How to read the label
4 checksGrams to magnesium
Laxative use is occasional use
Soak or swallow
USP grade
OTC Epsom salt is labelled magnesium sulfate USP with no inactive ingredients.1
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
8 answersDo Epsom salt baths raise magnesium levels?
There is no controlled evidence that they do. A 2017 review concluded that claims for transdermal magnesium, including salt baths, are scientifically unsupported. A warm bath may feel good, but it is not a proven way to raise body magnesium.11
Does Epsom salt work for constipation?
Do Epsom salt soaks help sore muscles or cramps?
How much Epsom salt is safe to drink?
Can Epsom salt cause magnesium poisoning?
Is magnesium sulfate a good daily magnesium supplement?
It can raise blood magnesium: 450 mg/day as sulfate raised plasma magnesium about as much as citrate or oxide in a 24-week trial, though urinary magnesium rose less than with citrate. Most supplements use other forms.10
Does Epsom salt interact with medicines?
Can I use Epsom salt while pregnant or breastfeeding?
The laxative label says to ask a health professional before use in pregnancy or breastfeeding. The pregnancy warnings for prolonged hospital infusions (more than 5 to 7 days) do not describe occasional oral laxative use. LactMed notes that infants absorb oral magnesium poorly, so maternal magnesium is not expected to raise a breastfed baby's magnesium.11425
Sources
25 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
25 sources- 1Epsom Salt (magnesium sulfate USP, heptahydrate) granule: OTC Drug Facts label (saline laxative)Label Vi-Jon, LLC via DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 2PubChem compound summary: Magnesium sulfate heptahydrate (CID 24843)Database National Library of Medicine, 2026 · pubchem.ncbi.nlm.nih.gov
- 3PubChem compound summary: Magnesium sulfate (CID 24083)Database National Library of Medicine, 2026 · pubchem.ncbi.nlm.nih.gov
- 4Epsom Salt (magnesium sulfate) granule, for solution: OTC label with soaking directionsLabel Target Corporation via DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 5Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults.Review Adv Nutr, 2023 · PMID 37487817
- 6Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation.RCT Clin Gastroenterol Hepatol, 2014 · PMID 24342746
- 7Time to treatment response of a magnesium- and sulphate-rich natural mineral water in functional constipation.RCT Nutrition, 2019 · PMID 31170680
- 8The osmotic laxative magnesium sulphate activates the ileal brake.Crossover RCT Aliment Pharmacol Ther, 2000 · PMID 10792122
- 9Magnesium Sulfate-Rich Natural Mineral Waters in the Treatment of Functional Constipation-A Review.Review Nutrients, 2020 · PMID 32664341
- 10Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double-Blind, Placebo-Controlled Intervention Trial.RCT J Am Heart Assoc, 2022 · PMID 35253448
- 11Myth or Reality-Transdermal Magnesium?Review Nutrients, 2017 · PMID 28788060
- 12Fatal Hypermagnesemia: an acute ingestion of Epsom Salt in a patient with normal renal function.Observational Caspian J Intern Med, 2018 · PMID 30510660
- 13Case report: Near-fatal hypermagnesemia resulting from the use of Epsom salts in a patient with normal renal function.Observational Front Med (Lausanne), 2024 · PMID 39021819
- 14Magnesium Sulfate Injection, USP 50%: prescribing informationLabel Fresenius Kabi USA via DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 15Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: a double-blind, randomized, placebo-controlled study.RCT Eur J Nutr, 2017 · PMID 26582579
- 16Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.RCT Lancet, 2002 · PMID 12057549
- 17Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study.RCT Forsch Komplementmed, 2016 · PMID 27924798
- 18Magnesium for skeletal muscle cramps.Meta-analysis Cochrane Database Syst Rev, 2020 · PMID 32956536
- 19Ciprofloxacin tablets: prescribing information (administration with multivalent cations)Label DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 20Doxycycline hyclate capsules: prescribing information (drug interactions)Label DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 21Alendronate sodium tablets: prescribing information (calcium supplements and antacids)Label DailyMed (NLM), 2026 · dailymed.nlm.nih.gov
- 22Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.Meta-analysis Cochrane Database Syst Rev, 2010 · PMID 21069663
- 23Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department.Meta-analysis Cochrane Database Syst Rev, 2014 · PMID 24865567
- 24Intravenous magnesium sulfate for treating children with acute asthma in the emergency department.Meta-analysis Cochrane Database Syst Rev, 2016 · PMID 27126744
- 25Magnesium Sulfate. Drugs and Lactation Database (LactMed).Database National Institute of Child Health and Human Development, 2026 · PMID 30000398
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| definition, safety, FAQ | A–Z audit. PubMed search for 2023–2026 trials and meta-analyses of oral magnesium sulfate or sulfate-rich mineral water found none to add. Shortened the definition to 140 characters; added breastfeeding to the pregnancy note and FAQ from the LactMed magnesium sulfate record (already source 25); cut the FAQ from 11 to 8 by removing three items already covered in the definition, evidence and hospital-use sections. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| all | New page. Every PMID checked with NCBI E-utilities (esummary title, year and journal) and its abstract read with efetch, including the LactMed record. OTC Epsom salt labels, the magnesium sulfate injection label and the ciprofloxacin, doxycycline and alendronate labels read on DailyMed on the date shown; molecular weights from PubChem. Hospital injection uses are described in their own section and not graded as supplement evidence. | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.